Last reviewed · How we verify

NCT05088668

Augmented Reality for Shoulder Pain and Scapular Dyskinesis

Suspended NA Last updated 22 November 2022
What this trial tests

NA trial testing Augmented reality in Shoulder Pain in 52 participants. Suspended.

Timeline
27 October 2021
Primary endpoint
1 May 2022
1 December 2028

Quick facts

Lead sponsorRuben Fernandez Matias
PhaseNA
StatusSuspended
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment52
Start date27 October 2021
Primary completion1 May 2022
Estimated completion1 December 2028
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Ruben Fernandez Matias

Who can join

Adults 18 to 75, any sex, with Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to analyze whether an Augmented Reality based scapular stabilization exercise program is more effective than conventional programs in patients with chronic shoulder pain and Scapular Dyskinesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Augmented reality

Trials testing the same drug.

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Other Ruben Fernandez Matias trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05088668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing